<code id='2ED6BCBD04'></code><style id='2ED6BCBD04'></style>
    • <acronym id='2ED6BCBD04'></acronym>
      <center id='2ED6BCBD04'><center id='2ED6BCBD04'><tfoot id='2ED6BCBD04'></tfoot></center><abbr id='2ED6BCBD04'><dir id='2ED6BCBD04'><tfoot id='2ED6BCBD04'></tfoot><noframes id='2ED6BCBD04'>

    • <optgroup id='2ED6BCBD04'><strike id='2ED6BCBD04'><sup id='2ED6BCBD04'></sup></strike><code id='2ED6BCBD04'></code></optgroup>
        1. <b id='2ED6BCBD04'><label id='2ED6BCBD04'><select id='2ED6BCBD04'><dt id='2ED6BCBD04'><span id='2ED6BCBD04'></span></dt></select></label></b><u id='2ED6BCBD04'></u>
          <i id='2ED6BCBD04'><strike id='2ED6BCBD04'><tt id='2ED6BCBD04'><pre id='2ED6BCBD04'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:1
          Cosmetics
          Alberto Pellaschiar/AP

          WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

          Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

          advertisement

          But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Eisai exec who led development of Alzheimer’s drug to retire
          Eisai exec who led development of Alzheimer’s drug to retire

          IvanCheungisretiringaschairmanofEisai'sU.S.operationsandglobalheadofitsAlzheimer’sdiseaseunit.Chanta

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Biden declares emergency in flood

          LiveAgeneralviewofafloodedarea,inLudlow,Vt.,July10,2023.Instagram@henrysweatherchannel/viaReutersU.S